13F-HR filed by SECTORAL ASSET MANAGEMENT INC
SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 65 holding rows worth $856,296,000.
- Accession
- 0001104659-17-032751
- Filer
- CIK 1274413
- Filed
- 2017-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2017
A holdings report, 65 entries on the cover page, a total value of $856,296,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $856,296,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Merck & Co.,Inc. | 58933Y105 | COM | 720,982 | $45,811,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 342,350 | $42,640,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 1,149,372 | $39,320,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 851,019 | $36,849,000 | thousands by filing date | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 472,296 | $35,077,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 272,066 | $33,853,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 261,691 | $32,764,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 4,311,696 | $30,742,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 357,341 | $30,278,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 173,679 | $30,260,000 | thousands by filing date | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 691,010 | $30,128,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 391,989 | $29,274,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 315,233 | $27,671,000 | thousands by filing date | |
| TELADOC HEALTH INC | 87918A105 | COM | 1,058,553 | $26,464,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 753,821 | $24,190,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 610,743 | $23,813,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 604,041 | $23,672,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 671,113 | $23,073,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 28,672 | $21,976,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 200,479 | $18,859,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 581,222 | $18,088,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 389,423 | $17,660,000 | thousands by filing date | |
| K2M GROUP HLDGS INC | 48273J107 | COM | 836,520 | $17,157,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 713,119 | $14,833,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 504,568 | $13,538,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 489,267 | $12,990,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 1,279,247 | $12,869,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 345,582 | $12,735,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 2,482,621 | $11,792,000 | thousands by filing date | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 202,499 | $8,531,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 730,150 | $8,148,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 141,046 | $7,869,000 | thousands by filing date | |
| ENVISION HEALTHCARE CORP | 29414D100 | COM | 125,050 | $7,668,000 | thousands by filing date | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 217,480 | $7,455,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 839,774 | $6,861,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 460,300 | $6,145,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 63,520 | $4,986,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 53,300 | $4,971,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 225,340 | $4,797,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 133,499 | $4,702,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 90,390 | $3,804,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 81,575 | $3,720,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 351,135 | $3,455,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 126,400 | $3,346,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 11,711 | $3,202,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 51,200 | $2,990,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 143,240 | $2,457,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 78,700 | $2,349,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 17,145 | $2,292,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 5,695 | $2,207,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 110,599 | $1,937,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 11,350 | $1,937,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 137,500 | $1,602,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 67,200 | $1,396,000 | thousands by filing date | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 32,155 | $1,291,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 24,899 | $1,276,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 14,950 | $1,137,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 253,178 | $914,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 12,199 | $867,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 28,799 | $852,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 128,272 | $789,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 75,500 | $786,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 20,224 | $485,000 | thousands by filing date | |
| PROFOUND MED CORP | 74319B106 | COM | 495,900 | $387,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 201,660 | $309,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-17-032751 | this filing | 2017-05-15 | acceptance time not in the bulk data set |